U.S. Defense Reports Immuron’s Travelan® demonstrates broad reactivity to Vibrio cholera strains from Southeast Asia indicating broad potential for prevention of travelers’ diarrhea September 4, 2019 - NASDAQ Companies 0 » View More News for September 04, 2019